Lifestyle interventions on Alzheimer's disease and related dementias: Social and structural determinants of implementation effectiveness and sustainability.
26 affiliations
- 1Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- 2Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- 3Department of Epidemiology and Biostatistics, Temple University College of Public Health, Philadelphia, Pennsylvania, USA.
- 4Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
- 5Kessler Foundation, West Orange, New Jersey, USA.
- 6Department of Epidemiology, Celia Scott Weatherhead School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana, USA.
- 7Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, California, USA.
- 8Penn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- 9Departments of Psychiatry, Neurology, and Population Health, NYU Grossman School of Medicine, New York University, New York, New York, USA.
- 10Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
- 11Department of Neurology and Alzheimer Center, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
- 12Department of Neurology and Innovation Center for Neurological Disorders, Xuanwu Hospital, Capital Medical University, Beijing, China.
- 13Department of Public Health Sciences, University of California Davis, Davis, California, USA.
- 14Center for Innovation in Healthy and Resilient Aging, Arizona State University, Phoenix, Arizona, USA.
- 15Edward and Pearl Fein Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, USA.
- 16Virginia Geriatric Education Center, Virginia Center on Aging, Virginia Commonwealth University, Richmond, Virginia, USA.
- 17School of Public Health, George Mason University, Fairfax, Virginia, USA.
- 18University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
- 19Department of Behavioral Health, Brooke Army Medical Center, San Antonio, Texas, USA.
- 20Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
- 21Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- 22Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- 23Department of Pharmaceutical Sciences, Irma Lerma Rangel College of Pharmacy, Texas A&M University Health Science Center, Kingsville, Texas, USA.
- 24Hopkins Economics of Alzheimer's Disease and Services Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
- 25School of Nursing, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- 26Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Abstract
Alzheimer's disease and related dementias (ADRD) pose a global public health challenge, and epidemiological evidence underscores profound disparities in ADRD risk and outcomes that are rooted in social/structural determinants of health (S/SDOH). Yet, these determinants are seldom integrated into intervention design or implementation strategies. In this review, we identify S/SDOH that influence the equitable implementation of evidence-based ADRD lifestyle interventions across diverse groups and explore implications. Guided by Bronfenbrenner's ecological model, we: (1) examined theoretical foundations, focusing on how macrosystem and microsystem factors modulate implementation effectiveness across multiple intervention modalities; (2) synthesized empirical literature, highlighting successful and suboptimal intervention outcomes in marginalized populations; (3) identified critical gaps, especially where evidence on implementation across socially defined groups is lacking; and (4) discussed implications for enhancing design and policy for equitable ADRD intervention delivery. Our goal is to produce a conceptual and empirical synthesis that offers actionable guidance for clinicians, researchers, and policy makers.
Related
- Effectiveness, cost-effectiveness and implementation of WHO psychological interventions for migrant populations resettled in Italy: study protocol for the ADVANCE hybrid type-I randomized controlled trial
- Bridging policy and implementation science: operationalising political and structural determinants for health policy implementation evaluation.
- Effectiveness of pharmacological interventions for pain after laparoscopic sleeve gastrectomy: protocol for a systematic review and network meta-analysis
- Effectiveness of Nursing Interventions on Stress and Functional Capacity Among Patients After Coronary Artery Bypass Grafting (CABG): A Randomized Controlled Trial
- Effectiveness of dynamic neuromuscular stabilization-based interventions for nonspecific low back pain: a systematic review and meta-analysis
BibTeX
@article{bey2026lifestyle,
title = {{Lifestyle interventions on Alzheimer's disease and related dementias: Social and structural determinants of implementation effectiveness and sustainability.}},
author = {Ganga S Bey and Sheina Emrani and Erin R Kulick and Cristina A F Román and Ileana De Anda-Duran and Miriam T Ashford and Rory Boyle and Omonigho Michael Bubu and Jasmine Dixon and Sanne Franzen and Pei-Yang Gao and Kristen George and M Aaron Guest and Margo B Heston and Patricia Heyn and Daija Jackson and Sudarshan Krishnamurthy and Jeffrey S Phillips and Awaale F Rirash and Jayalakshmi Viswanathan and Preeti Pushpalata Zanwar and Megan Zuelsdorff and Shana D Stites},
journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
year = {2026},
month = nov,
doi = {10.1002/alz.71957},
url = {https://europepmc.org/article/MED/43010124},
note = {CC BY},
}
RIS
TY - JOUR
TI - Lifestyle interventions on Alzheimer's disease and related dementias: Social and structural determinants of implementation effectiveness and sustainability.
AU - Ganga S Bey
AU - Sheina Emrani
AU - Erin R Kulick
AU - Cristina A F Román
AU - Ileana De Anda-Duran
AU - Miriam T Ashford
AU - Rory Boyle
AU - Omonigho Michael Bubu
AU - Jasmine Dixon
AU - Sanne Franzen
AU - Pei-Yang Gao
AU - Kristen George
AU - M Aaron Guest
AU - Margo B Heston
AU - Patricia Heyn
AU - Daija Jackson
AU - Sudarshan Krishnamurthy
AU - Jeffrey S Phillips
AU - Awaale F Rirash
AU - Jayalakshmi Viswanathan
AU - Preeti Pushpalata Zanwar
AU - Megan Zuelsdorff
AU - Shana D Stites
PY - 2026
DA - 2026/11/01
JO - Alzheimer's & dementia : the journal of the Alzheimer's Association
DO - 10.1002/alz.71957
UR - https://europepmc.org/article/MED/43010124
AB - Alzheimer's disease and related dementias (ADRD) pose a global public health challenge, and epidemiological evidence underscores profound disparities in ADRD risk and outcomes that are rooted in social/structural determinants of health (S/SDOH). Yet, these determinants are seldom integrated into intervention design or implementation strategies. In this review, we identify S/SDOH that influence the equitable implementation of evidence-based ADRD lifestyle interventions across diverse groups and explore implications. Guided by Bronfenbrenner's ecological model, we: (1) examined theoretical foundations, focusing on how macrosystem and microsystem factors modulate implementation effectiveness across multiple intervention modalities; (2) synthesized empirical literature, highlighting successful and suboptimal intervention outcomes in marginalized populations; (3) identified critical gaps, especially where evidence on implementation across socially defined groups is lacking; and (4) discussed implications for enhancing design and policy for equitable ADRD intervention delivery. Our goal is to produce a conceptual and empirical synthesis that offers actionable guidance for clinicians, researchers, and policy makers.
SN - 1552-5260
SN - 1552-5279
ER -